Kvantify raises DKK 37 million to accelerate quantum technology in life sciences
The Aarhus-based scale-up, which originated at Aarhus University and is domiciled at INCUBA, bridges the gap between quantum technology and drug development with proprietary algorithms that can optimise discovery pipelines and strengthen the medicine of the future.
The investment comes from both existing and new investors, including 2degrees, Lundbeckfonden, EIFO, Dreamcraft Ventures, QAI Ventures, Nordic Makers, Anterio Consult and Research GmbH, and 2xN. This was announced by Kvantify on LinkedIn.
‘This investment enables us to accelerate our strategic, technological and commercial initiatives and strengthen our position in the market. Our mission remains to solve some of the world's most complex computational challenges for the benefit of both business and society – with a focus on life science,’ says Nikolaj Zinner, co-founder & CSO.
We look forward to following the journey and seeing how Kvantify continues to put both Aarhus and Denmark on the world map.
